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DOI 10.1186/s13073-017-0413-5RESEARCH Open AccessDNA methylation changes at infertility
genes in newborn twins conceived by
in vitro fertilisation
Juan E. Castillo-Fernandez1, Yuk Jing Loke2, Sebastian Bass-Stringer2, Fei Gao3, Yudong Xia3, Honglong Wu3,
Hanlin Lu3, Yuan Liu3, Jun Wang3,4,5,6, Tim D. Spector1*, Richard Saffery7,8*, Jeffrey M. Craig2,7*†
and Jordana T. Bell1*†Abstract
Background: The association of in vitro fertilisation (IVF) and DNA methylation has been studied predominantly
at regulatory regions of imprinted genes and at just thousands of the ~28 million CpG sites in the human
genome.
Methods: We investigated the links between IVF and DNA methylation patterns in whole cord blood cells
(n = 98) and cord blood mononuclear cells (n = 82) from newborn twins using genome-wide methylated DNA
immunoprecipitation coupled with deep sequencing.
Results: At a false discovery rate (FDR) of 5%, we identified one significant whole blood DNA methylation
change linked to conception via IVF, which was located ~3 kb upstream of TNP1, a gene previously linked to
male infertility. The 46 most strongly associated signals (FDR of 25%) included a second region in a gene also
previously linked to infertility, C9orf3, suggesting that our findings may in part capture the effect of parental
subfertility. Using twin modelling, we observed that individual-specific environmental factors appear to be the main
overall contributors of methylation variability at the FDR 25% IVF-associated differentially methylated regions, although
evidence for methylation heritability was also obtained at several of these regions. We replicated previous findings of
differential methylation associated with IVF at the H19/IGF2 region in cord blood mononuclear cells, and we validated
the signal at C9orf3 in monozygotic twins. We also explored the impact of intracytoplasmic sperm injection on the FDR
25% signals for potential effects specific to male or female infertility factors.
Conclusions: To our knowledge, this is the most comprehensive study of DNA methylation profiles at birth and IVF
conception to date, and our results show evidence for epigenetic modifications that may in part reflect parental
subfertility.
Keywords: In vitro fertilisation (IVF), Epigenomics, DNA methylation, MeDIP-seq* Correspondence: tim.spector@kcl.ac.uk; richard.saffery@mcri.edu.au;
jeff.craig@mcri.edu.au; jordana.bell@kcl.ac.uk
†Equal contributors
1Department of Twin Research and Genetic Epidemiology, King’s College
London, SE1 7EH London, UK
7Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia
2Early Life Epigenetics, Murdoch Childrens Research Institute, Royal Children’s
Hospital, Parkville, VIC, Australia
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Castillo-Fernandez et al. Genome Medicine  (2017) 9:28 Page 2 of 15Background
As the frequency of in vitro fertilisation (IVF) treatment
increases worldwide, much research effort has focused
on exploring both short- and long-term health outcomes
associated with conception via IVF, with contradictory
results. A number of studies have observed associations
with adverse perinatal and obstetric outcomes, including
low birth weight, preterm birth, perinatal mortality,
congenital malformations, placental complications, and
increased frequency of imprinting disorders such as
Angelman syndrome and Beckwith-Wiedemann syn-
drome [1–4]. On the other hand, parallel efforts have re-
ported that these associations are not attributed to IVF
treatment itself, but rather to multiple pregnancy or
parental subfertility, both common factors in IVF births
[5, 6]. Further research is required to identify potential
factors associated with conception via IVF, including not
only health outcomes but also biological consequences
such as epigenetic modifications.
Given that birth weight and imprinting disorders are
controlled at least in part by epigenetic factors [7, 8],
IVF may have an influence on epigenetic profiles, poten-
tially resulting in changes that persist well after birth
and over the life course. Epigenetic mechanisms are con-
sidered possible mediators of the developmental origins
of health and disease [9]; therefore, an assessment of the
influence of IVF on DNA methylation profiles may give
some insights into mechanisms underlying potential re-
lated health outcomes. Establishment of DNA methyla-
tion profiles in the germ line and embryo takes place
early in development [10]. Theoretically, this epigenetic
reprogramming could therefore be influenced by IVF-
related interventions that occur very early, prior to
blastocyst implantation. Indeed, induction of ovulation,
embryo culturing, and cryopreservation, among others,
have all been linked to specific alterations in DNA
methylation in mice, although results are somewhat
inconsistent [11–13].
Most studies in humans comparing naturally and IVF-
conceived newborns have interrogated DNA methylation
alterations targeting almost exclusively imprinted differ-
entially methylated regions (DMRs). These studies have
reported increased epigenetic variability at the KvDMR1,
PEG1, and H19 DMRs in umbilical cord blood [14], hy-
pomethylation of the H19 and MEST DMRs in placenta
[15], and hypomethylation of the H19 DMR in buccal
epithelium [16] in individuals conceived by IVF. High-
throughput approaches using bead array technology
have also interrogated DNA methylation in IVF in a
genome-wide manner. Katari et al. [17] reported differ-
ential methylation at 78 genes in cord blood and 40 in
placenta with at least two differentially methylated CpG
sites (P ≤ 0.08) when looking across the promoters of
736 genes (GoldenGate Array, Illumina) in ten cases and13 controls. A more extensive study using the promoter-
enriched Illumina Infinium HumanMethylation27 bead
array in cord blood samples from ten IVF cases and
eight controls reported a total of 24 genes with at least
two differentially methylated CpG sites (P < 0.05) [18].
More recently, a study used the genome-wide Illumina
Infinium HumanMethylation450 bead array in samples
from 38 IVF-conceived newborns followed by fresh em-
bryo transfer, 38 IVF-conceived followed by cryopre-
served embryo transfer, 18 born to subfertile parents
after conception by intrauterine insemination, and 43
controls born to fertile parents [19]. This platform inter-
rogates CpG sites across the whole genome, although
with a limited coverage since it targets gene-centric an-
notations [20]. The authors identified differential methy-
lation at multiple sites, including metastable epialleles.
Here, we interrogated evidence for differential methy-
lation between IVF and non-IVF newborn twins in a
more comprehensive manner by conducting epigenome-
wide association scans (EWAS) [21] using methylated
DNA immunoprecipitation followed by deep sequencing
(MeDIP-seq) [22] genome-wide in samples from cord
blood, and its mononuclear fraction, collected at birth
from IVF and non-IVF twins. The use of twins in this
study allowed the partition of the observed variance in
DNA methylation into genetic and environmental fac-
tors. The approach also avoids potential spurious associ-
ations due to an imbalanced number of multiple and
single pregnancies between conception method groups.
Methods
Subjects and sample collection
The study included 47 IVF and 60 non-IVF newborn
twins (from 54 twin pairs) from the Peri/postnatal
Epigenetic Twins Study (PETS), Melbourne, Australia.
Recruitment and full study procedure have been de-
scribed previously [23, 24]. Cord blood was collected at
birth and used to process mononuclear cells by Ficoll
gradient centrifugation as described previously [25].
Whole blood cells (WBCs) from cord blood were avail-
able for a total of 98 twins (40 IVF and 58 non-IVF) and
cord blood mononuclear cells (CBMCs) for a total of 82
twins (35 IVF and 47 non-IVF). Maternal age and
method of conception were determined via question-
naire at recruitment (18–20 weeks gestation). Twins of
mothers who said yes to IVF or intracytoplasmic sperm
injection (ICSI) treatment were classified as IVF regard-
less of the use of ovulation induction medication or
other fertility treatments. Maternal smoking status was
collected via questionnaire on recruitment and at 24 and
36 weeks of pregnancy. Birth weight was collected
during the immediate neonatal period. Zygosity and
chorionicity were determined by physical examination of
the inter-placental membranes at birth, and by genetic
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Pregnancy complications were recorded and are shown
in Additional file 1: Table S1.
DNA methylation profiling
MeDIP-seq was performed at BGI-Shenzhen, Shenzhen,
China. Extracted DNA was fragmented using a Covaris
sonication system and sequencing libraries were pre-
pared from 5 μg fragmented genomic DNA. End repair,
<A > base addition and adaptor ligation steps were
performed using Illumina’s Single-End DNA Sample
Prep kit. Adaptor-ligated DNA was immunoprecipitated
by anti-5mC using a commercial antibody (Diagenode)
and MeDIP products were validated by quantitative
PCR. MeDIP DNA was purified with ZYMO DNA Clean
& Concentrator-5 columns and amplified using adaptor-
mediated PCR. DNA fragments between 200 and 500 bp
in size were gel-excised, and the amplification quality
and quantity were evaluated by Agilent BioAnalyzer
analysis. The libraries were subjected to highly parallel
50-bp single-end sequencing on the Illumina GAII plat-
form. All sequencing data passed initial quality checks
for base composition (no exclusions) using FASTQC
v0.10.0. For each individual, ~30 million reads were gen-
erated and mapped onto hg19 using BWA. After remov-
ing duplicates, we filtered data using quality score Q10.
We quantified methylation levels using MEDIPS [26],
producing the mean relative methylation score (RPM) in
500-bp bins (overlap of 250 bp) across the genome.
Altogether, there were 11,524,145 windows and these
were used for the analyses. Bins with RPM values of zero
in more than 50% of the samples were excluded, resulting
in 9,592,803 (WBC) and 9,285,089 (CBMC) bins used in
downstream analyses.
Epigenome-wide IVF-DMR analyses
Normalised (N(0,1)) methylation scores in each genomic
bin were regressed using a linear mixed-effects model to
account for twin structure (lme4 package [27] in R [28]).
Tissue type, birth weight, sex, maternal smoking, 260/
280 ratio, DNA concentration, and the loadings of the
first five principal components were used as covariates
and included as fixed effects in the model. Family and
zygosity were included as random effects in the linear
mixed model. The principal components were included
to account for unknown sources of variation, such as
cell heterogeneity. Correction for multiple testing was
performed by a Benjamini-Hochberg false discovery rate
(FDR) calculation.
Variance decomposition of WBC IVF-DMRs
The contribution of additive genetic (A), common envir-
onmental (C), and unique environmental (E) factors to
DNA methylation was estimated using the ACE modelbased on the classic twin design [29]. The model was fit-
ted using the OpenMX statistical package [30]. RPM
values without adjustment for covariates were used to
estimate the ACE proportions.
Statistical analysis
Pairwise correlations and principal components analysis
were performed using RPM values across all bins with
values > 0 in at least 50% of the samples. Hierarchical
clustering was performed using Euclidean distance as a
measure of dissimilarity and average linkage clustering.
Validation analysis
Genomic DNA (500 ng) was bisulphite converted using
the MethylEasy Exceed Rapid Bisulphite Modification
Kit (Human Genetic Signatures, North Ryde, NSW,
Australia). Primers to target the regions in TNP1 and
C9orf3 were designed using the EpiDesigner tool (Seque-
nom Inc., Herston, QLD, Australia). The H19 CTCF6
region was the same used in a previous study [25]. Primers,
genomic coordinates, and PCR conditions are shown in
Additional file 1: Table S2. Methylation levels were
determined by EpiTYPER on the MassARRAY System
(Sequenom Inc., Herston, QLD, Australia). Statistical ana-
lysis considered the average of two to three technical repli-
cates and were performed using data on single CpG sites.
Results
Genome-wide methylation profiles in twins
We profiled DNA methylation levels from a total of 107
newborn twins (47 conceived via IVF and 60 conceived
in vivo) in WBCs and CBMCs. Details of any fertility
treatment used and demographic characteristics that
represent potential confounders of DNA methylation
levels at birth, such as sex, birth weight, maternal age,
and maternal smoking status, are shown in Table 1. We
first explored the genome-wide patterns of DNA methy-
lation variability in the dataset. Principal component
analysis was used to identify factors that were signifi-
cantly associated with genome-wide variability in DNA
methylation profiles. The first five principal components
in the dataset, which explained ~13% of the total
variance in DNA methylation, were at least nominally
associated (P < 0.05) with sample type (WBCs versus
CMBCs), birth weight, maternal smoking, and con-
ception method (Fig. 1a).
We next estimated the within twin-pair correlation
patterns in methylation profiles of twin pairs available
in both datasets using Pearson’s correlation. In con-
cordance with previous studies [7], we observed
higher median correlation within monozygotic (MZ)
twin pairs compared to dizygotic (DZ) twin pairs
(Fig. 1b). Previous studies have shown that twin chor-
ionicity can have an effect on within-pair DNA
Table 1 Breakdown of samples used for the identification of IVF-DMRs and potential covariates
Group Total number of
twins (number of
complete sets)
Zygosity and
chorionicitya
Sexb Birth weight
(kg): mean(sd)
Maternal age
(years): mean (sd)
Maternal smoking
(percentage smokers)
Ovarian
stimulation
ICSI GIFT Frozen
embryo
WBCs
IVF 40 (20) 10 MZ MC
30 DZ DC
18 (F)
22 (M)
2.57 (4.77) 36 (4) 20% 6 (No)
34 (Yes)
22 (No)
18 (Yes)
- 28 (No)
12 (Yes)
Non-IVF 58 (29) 14 MZ MC
12 MZ DC
32 DZ DC
34 (F)
24 (M)
2.58 (3.99) 32 (5) 28% 56 (No)
2 (Yes)
- 56 (No)
2 (Yes)
-
CBMCs
IVF 35 (16) 9 MZ MC
1 MZ DC
25 DZ DC
16 (F)
19 (M)
2.50 (4.42) 35 (5) 23% 1 (No)
34 (Yes)
14 (No)
21 (Yes)
- 24 (No)
11 (Yes)
Non-IVF 47 (22) 12 MZ MC
10 MZ DC
25 DZ DC
30 (F)
17 (M)
2.60 (3.48) 32 (4) 28% 45 (No)
2 (Yes)
- 45 (No)
2 (Yes)
-
aMZ monozygotic, DZ dizygotic, MC monochorionic, DC dichorionic
bF female, M male
GIFT gamete intra-fallopian transfer, ICSI intracytoplasmic sperm injection, sd standard deviation
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tion of effect across tissues [7, 25, 31]. In our study,
we did not observe significant chorionicity-related
methylation differences (Fig. 1b), but the number of
MZ twins within chorionicity categories was relatively
low (n = 8 monochorionic and n = 5 dichorionic pairs).a
b
Fig. 1 Global methylation patterns. a Biological factors associated with prin
marked with an asterisk were only available in a subset of the sample (n =
body mass index, DC dichorionic, DZ dizygotic, MC monochorionic, MZ moInterestingly, the method of conception showed
methylation profile differences within MZ twin pairs.
MZ IVF twins had higher median correlation com-
pared to MZ non-IVF twins in WBCs, but the oppos-
ite trend was observed in CBMCs, and in both cases
the MZ IVF sample was very small (n = 3).cipal components of variation of methylation profiles. Variables
54). b Within-pair methylation correlation in WBCs and CBMCs. BMI
nozygotic, PC principal component
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In order to identify tissue-independent and tissue-specific
IVF-associated DMRs, we compared DNA methylation
profiles in WBCs and CBMCs in relation to method of
conception adjusting for birth weight, sex, maternal smok-
ing, and the first five principal components, which partly
capture cell heterogeneity. Epigenome-wide analyses of
DNA methylation in relation to method of conception did
not identify genome-wide significant signals in the CBMCs
subset or in the combined CBMC and WBC datasets, after
correction for multiple testing. In WBCs alone, one signifi-
cant DMR was observed at a FDR of 5% (Fig. 2). This was
located ~3 kb upstream of TNP1 (chr2:217,726,751–
217,727,250), which encodes a transition nuclear protein
that replaces histones and is subsequently replaced by
protamines during spermiogenesis. A deletion in the pro-
moter region of this gene, which reduces its expression,
has been reported in infertile men [32]. Methylation up-
stream of TNP1 might have an impact on its expression.
In mice, methylation changes during spermatogenesis have
been observed at TNP1, which suggests a role of methyla-
tion in the regulation of this gene [33]. To explore the
biological characteristics of the top-ranked results in the
IVF epigenome-wide analyses we selected a more liberal
threshold of FDR 25%, at which 46 IVF-DMRs were iden-
tified (Table 2). Interestingly, the third-ranked DMR
genome-wide (Additional file 1: Figure S1) was located in
the first intron of C9orf3 (chr9:97,504,001–97,504,500),Fig. 2 TNP1 IVF-DMR. Methylation values (RPM) at the top IVF-DRM identifiwhich has been associated with polycystic ovary syndrome
in women [34] and development of erectile dysfunction
after radiotherapy for prostate cancer in men [35]. An-
other signal within this list was located in intron 1 of
STOX2 (chr4:184,814,001–184,814,500), whose reduced
expression has been implicated in pre-eclampsia [36].
Since adverse perinatal outcomes may be associated with
maternal age, we further adjusted for this covariate and
observed that the 46 FDR 25% WBC IVF-DMRs remained
significant (Table 2).
The non-IVF group included a small number (n = 4) of
newborns conceived with other types of fertility treat-
ments not equivalent to IVF, such as gamete intra-
fallopian transfer (GIFT) and ovarian stimulation. We
re-analysed the 46 FDR 25% WBC IVF-DMRs excluding
GIFT (n = 2) and non-IVF ovarian stimulation (n = 2)
controls and observed that conclusions remained un-
changed (Additional file 1: Table S3).
Hierarchical clustering using DNA methylation levels
at these 46 FDR 25% DMRs alone grouped twins by
method of conception, assigning 38 out of 40 IVF twins
and 57 out of 58 non-IVF twins to the correct group
(Fig. 3). We also explored these signals with respect to
functional annotations. A total of ten FDR 25% WBC
IVF-DMRs overlapped CpG sites previously shown to be
dynamic during development [37], 20 overlapped DNase
I hypersensitivity sites (wgEncodeRegDnaseClusteredV3)
[38], one overlapped a CpG island (cpgIslandEx) [39],ed ~3 kb upstream of TNP1 in WBCs
Table 2 FDR 25% WBC IVF-DMRs
Chromosome Start End P FDR adjusted P P (adjusted for maternal age) Gene namea Gene starta Gene enda
Chr2 217726751 217727250 2.30E-09 0.0221 6.40E-10 AC007557.1 217735495 217736362
TNP1 217724181 217724787
Chr5 178761751 178762250 5.43E-08 0.1244 1.76E-05 ADAMTS2 178537852 178772431
Chr9 97504001 97504500 5.83E-08 0.1244 5.14E-07 C9orf3 97488983 97849441
Chr5 9275751 9276250 5.86E-08 0.1244 1.67E-06 SEMA5A 9035138 9546187
Chr4 184814001 184814500 7.95E-08 0.1244 4.96E-07 STOX2 184774584 184944679
Chr5 142488501 142489000 8.73E-08 0.1244 5.76E-07 ARHGAP26 142149949 142608576
Chr9 118148751 118149250 9.20E-08 0.1244 4.61E-06 DEC1 117904097 118164923
Chr9 118149001 118149500 1.04E-07 0.1244 3.47E-06 DEC1 117904097 118164923
Chr11 82654251 82654750 1.30E-07 0.1250 5.26E-08 C11orf82 82611017 82669319
PRCP 82534544 82681626
RAB30 82684175 82782965
Chr19 6165251 6165750 1.40E-07 0.1250 1.00E-06 RFX2 5993175 6199583
ACSBG2 6135258 6193112
MLLT1 6212966 6279959
Chr1 85522251 85522750 1.43E-07 0.1250 2.56E-07 WDR63 85464830 85598821
MCOLN3 85483765 85514182
Chr17 42569001 42569500 1.64E-07 0.1274 1.90E-05 GPATCH8 42472652 42580798
Chr4 141606501 141607000 2.03E-07 0.1274 1.59E-05 TBC1D9 141541919 141677274
Chr5 137736001 137736500 2.06E-07 0.1274 1.13E-06 REEP2 137774706 137782658
KDM3B 137688285 137772717
Chr5 150614501 150615000 2.14E-07 0.1274 2.23E-07 SLC36A3 150656323 150683327
GM2A 150591711 150650001
CCDC69 150560613 150603706
Chr17 36918251 36918750 2.32E-07 0.1274 2.02E-07 MLLT6 36861795 36886056
CISD3 36886488 36891297
CWC25 36956687 36981734
PIP4K2B 36921942 36956379
PCGF2 36890150 36906070
CTB-58E17.5 36905613 36906969
PSMB3 36908989 36920484
AC006449.1 36884086 36884451
Chr6 126138251 126138750 2.36E-07 0.1274 2.12E-06 NCOA7 126102307 126252266
Chr7 144431251 144431750 2.70E-07 0.1274 5.29E-09 TPK1 144149034 144533488
Chr12 70937251 70937750 2.76E-07 0.1274 1.83E-06 PTPRB 70910630 71031220
Chr4 141606251 141606750 2.80E-07 0.1274 1.50E-05 TBC1D9 141541919 141677274
Chr13 90019001 90019500 2.84E-07 0.1274 5.94E-07 - - -
Chr11 74179001 74179500 2.92E-07 0.1274 1.61E-09 LIPT2 74202757 74204778
POLD3 74204896 74380162
KCNE3 74165886 74178774
Chr12 99153001 99153500 3.93E-07 0.1637 2.44E-07 ANKS1B 99120235 100378432
APAF1 99038919 99129204
Chr2 223336751 223337250 4.47E-07 0.1788 2.00E-06 SGPP2 223289236 223425667
Chr8 120972001 120972500 4.98E-07 0.1869 3.26E-08 DEPTOR 120885957 121063152
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Table 2 FDR 25% WBC IVF-DMRs (Continued)
Chr17 38047001 38047500 5.25E-07 0.1869 7.83E-06 GSDMB 38060848 38076107
ZPBP2 38024417 38034149
IKZF3 37921198 38020441
ORMDL3 38077294 38083854
Chr4 64626751 64627250 5.45E-07 0.1869 2.67E-06 - - -
Chr16 87256751 87257250 5.51E-07 0.1869 2.12E-08 C16orf95 87117168 87351022
Chr19 10656751 10657250 5.77E-07 0.1869 1.42E-06 CDKN2D 10677138 10679735
ATG4D 10654571 10664094
KEAP1 10596796 10614417
AP1M2 10683347 10697991
KRI1 10663761 10676713
S1PR5 10623623 10628607
Chr7 2487251 2487750 5.85E-07 0.1869 2.03E-05 CHST12 2443223 2474242
Chr11 74178751 74179250 6.82E-07 0.2059 1.31E-07 KCNE3 74165886 74178774
LIPT2 74202757 74204778
POLD3 74204896 74380162
Chr10 119176501 119177000 6.87E-07 0.2059 1.11E-06 PDZD8 119040000 119134978
Chr22 34755251 34755750 7.32E-07 0.2094 1.76E-05 - - -
Chr6 161664751 161665250 7.42E-07 0.2094 2.93E-06 AGPAT4 161551011 161695093
Chr16 17161751 17162250 7.80E-07 0.2137 2.41E-06 XYLT1 17195626 17564738
Chr18 23695001 23695500 8.39E-07 0.2235 1.97E-06 PSMA8 23713816 23773319
SS18 23596578 23671181
Chr9 26364751 26365250 8.90E-07 0.2267 1.02E-06 - - -
Chr1 25227001 25227500 9.05E-07 0.2267 1.61E-05 RUNX3 25226002 25291612
Chr13 68877251 68877750 9.43E-07 0.2267 2.19E-05 - - -
Chr9 89126501 89127000 9.59E-07 0.2267 7.00E-06 - - -
Chr13 35317501 35318000 9.72E-07 0.2267 2.51E-05 - - -
Chr21 19575001 19575500 9.92E-07 0.2267 2.31E-06 CHODL 19273580 19639690
Chr2 169470001 169470500 1.06E-06 0.2307 4.35E-07 CERS6 169312372 169631644
Chr12 4310251 4310750 1.06E-06 0.2307 8.13E-05 - - -
Chr6 157136501 157137000 1.15E-06 0.2448 1.61E-06 ARID1B 157099063 157531913
Chr14 104067251 104067750 1.17E-06 0.2448 8.21E-06 APOPT1 104029299 104073860
BAG5 104022881 104029168
KLC1 104028233 104167888
RP11-73 M18.2 104029299 104152261
aFrom GENCODE v19
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leles [40] (Fig. 3).
Cell type-specific DNA methylation can impact the
profiles observed in a population of cells, such as in a
whole blood sample, and we therefore accounted for
blood cell type heterogeneity using a twofold approach.
First, we performed principal component analysis on the
methylation levels of the entire set of WBC samples, and
our main EWAS analyses above are corrected for the first
five principal components, which likely capture variationattributed to technical and biological factors, potentially
including cell heterogeneity. To assess whether the first
five principal components capture cell heterogeneity,
blood cell subtype counts were obtained through auto-
matic differential counting for a subset of the WBC sam-
ples (n = 54 twins, 22 IVF, and 32 non-IVF) and these
were compared against the distributions of the first five
principal components. The proportion of neutrophils, eo-
sinophils, and lymphocytes were associated (P < 0.05) with
the loadings of the second, third, and fourth principal
Fig. 3 WBC IVF-DMRs. Heatmap rows correspond to the 98 WBC samples while columns correspond to the 46 FDR 25% WBC IVF-DMRs. The
vertical colour bar indicates method of conception (IVF, green; non-IVF, blue). Top panel shows the fraction of variance explained by additive
genetic (A), shared environmental (C), and unique environmental (E) factors. Horizontal colour bars indicate overlap (violet) or absence (gray) of
dynamic CpG sites, DNase I hypersensitivity sites, or CpG islands with the DMR
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EWAS model used in this study took into account the
loadings of the first five principal components, these ana-
lyses already take into account the influence of cell hetero-
geneity to a certain extent.
Second, we re-analysed the 46 FDR 25% WBC IVF-
DMRs in the subset of 54 WBC samples with available
cell counts, adjusting for the proportion of neutrophils,
eosinophils, monocytes, and lymphocytes. We also per-
formed analyses adjusting for the loadings of the first
five principal components within this dataset alone.
Most results were concordant when comparing across all
models (Additional file 1: Table S4) and only five out the
46 FDR 25% WBC IVF-DMRs were not significant (P >
0.05) after adjusting for cell proportions (chr8:120,972,0
01–120,972,500, chr7:2,487,251–2,487,750, chr18:23,69
5,001–23,695,500, chr12:4,310,251–4,310,750, and chr1
4:104,067,251–104,067,750).
Variance decomposition of WBC IVF-DMRs
Given that epigenetic changes were potentially affecting
infertility genes, we wanted to investigate if the findings
may capture a genetic signature affecting DNA methyla-
tion that could be transmitted to offspring. We applied
twin variance decomposition analyses to partition the
total epigenetic variance into additive genetic (A) and
common (C) and unique (E) environmental components
(ACE) [29]. The ACE model was used to determine the
contribution of genetics, shared intrauterine environ-
ment due to shared maternal influences, and non-shared
(twin-specific) or stochastic factors to epigenetic vari-
ation. The mean contribution of additive genetic effects
(narrow-sense heritability) to DNA methylation across
the genome in different tissues from newborns has been
previously estimated to be between 0.05 and 0.12 [7]. Here
we estimated the average genome-wide narrow-sense her-
itability for DNA methylation in WBCs at 0.06. At the 46
FDR 25% WBC IVF-DMRs, the major contributors to
DNA methylation variation were non-shared or stochastic
events (Fig. 3). However, several FDR 25% IVF-DMRs had
evidence for heritability (A > 0.4), suggestive of genetic
effects underlying specific IVF-associated DNA methyla-
tion changes. These included an intronic region in DEC1
(chr9:118,148,751–118,149,500), a region 33 kb away from
XYLT1 (chr16:17,161,751–17,162,250), and an intergenic
region in chromosome 12 (chr12:4,310,251–4,310,750).
When looking at the two DMRs associated with infertility
genes, DNA methylation variation showed no evidence for
genetic effects (A = 0) near TNP1, while heritability at the
DMR in C9orf3 was estimated at 0.25.
Effects of IVF on imprinting
Previous studies have explored DNA methylation pat-
terns in IVF births specifically at imprinting controlregions (ICRs). We therefore assessed whether there was
an enrichment of differential methylation effects at 34
known ICRs [41] in our genome-wide results, but no
enrichment was observed (P > 0.05). However, when we
explored individual signals at candidate IVF-DMRs we
were able to replicate one previously reported ICR IVF-
associated DMR. Concordantly with previous IVF methyla-
tion studies in placental tissue [15] and buccal epithelium
[16], we observed hypomethylation in IVF twins at the sixth
CTCF binding site within the H19/IGF2 (H19 CTCF6)
DMR (Additional file 1: Figure S2). This association was
observed in CBMCs (P = 0.01), but not in WBCs.
Effects of ICSI
ICSI is a technique in IVF used to treat couples with
male-factor infertility [42]. In contrast to conventional
IVF where fertilisation occurs by placing spermatozoa
near an egg, ICSI consists of the direct injection of a se-
lected single sperm cell into the egg. This manipulation
may introduce additional risk factors [43]. To assess the
effect of ICSI on the 46 FDR 25% WBC IVF-DMRs we
adjusted for the use of this technology and also com-
pared the ICSI and the conventional IVF groups separ-
ately against the non-IVF group. After adjustment for
ICSI, the association weakened at several FDR 25% IVF-
DMRs (Table 3), suggesting that ICSI or paternal infer-
tility might have a role in these methylation changes.
One FDR 25% IVF-DMR signal (chr1:85,522,251–
85,522,750) appeared stronger after adjustment, suggest-
ing either a female infertility effect or that ICSI prevents
or corrects a methylation change that occurs in conven-
tional IVF. This DMR was located upstream of WDR63,
a gene mainly expressed in testis, fallopian tube, and ad-
renal gland [44].
Validation of IVF-DMRs
We pursued validation of the differential methylation
signals at the top associated DMR (located ~3 kb up-
stream of TNP1) and at the third-ranked DMR (located
in C9orf3), both in or near genes previously linked to
infertility. Altogether, four CpG sites were targeted for
validation using Sequenom’s EpiTYPER technology.
For the DMR in C9orf3, we were able to target two
CpG sites within the most-associated 500-bp bin in this
locus (Additional file 1: Figure S3). We assayed methyla-
tion levels in 36 MZ twins included in the discovery
EWAS and observed significantly higher methylation in
the IVF group, concordant with the MeDIP-seq
analysis, at both tested CpG sites in the C9orf3 locus
(P = 0.02 and 0.03, respectively), therefore validating
this signal using a different methylation profiling ap-
proach (Additional file 1: Figure S4).
For the TNP1 DMR we were unable to target CpGs
within the most associated 500-bp bin, and we therefore
Table 3 Effect of ICSI on the FDR 25% WBC IVF-DMRs
IVF (n = 40) versus
non-IVF (n = 58)
IVF (n = 34) versus non-IVF
(n = 58) adjusted for ICSI
Conventional IVF (n = 16)
versus non-IVF (n = 58)
ICSI (n = 18) versus
non-IVF (n = 58)
Chromosome Start End Estimate SE P Estimate SE P Estimate SE P Estimate SE P
Chr2 217726751 217727250 1.18 0.19 2.30E-09 1.45 0.26 7.71E-08 −1.42 0.26 7.44E-08 −1.16 0.27 1.29E-05
Chr5 178761751 178762250 −1.08 0.2 5.43E-08 −1.09 0.29 8.23E-05 0.87 0.30 1.89E-03 1.11 0.27 2.52E-05
Chr9 97504001 97504500 1.07 0.2 5.83E-08 0.77 0.27 2.77E-03 −0.88 0.31 2.67E-03 −1.30 0.25 1.95E-07
Chr5 9275751 9276250 1.09 0.19 5.86E-08 1.17 0.27 1.04E-05 −1.13 0.29 6.50E-05 −1.13 0.27 2.75E-05
Chr4 184814001 184814500 −0.96 0.18 7.95E-08 −0.97 0.24 3.94E-05 0.94 0.26 1.37E-04 1.15 0.23 8.35E-07
Chr5 142488501 142489000 −1.11 0.2 8.73E-08 −1.1 0.28 7.60E-05 1.25 0.31 5.16E-05 1.08 0.28 7.10E-05
Chr9 118148751 118149250 1.09 0.2 9.20E-08 1.35 0.28 1.28E-06 −1.30 0.29 8.90E-06 −1.02 0.28 1.68E-04
Chr9 118149001 118149500 1.08 0.2 1.04E-07 1.31 0.28 2.22E-06 −1.23 0.29 2.00E-05 −1.05 0.29 1.69E-04
Chr11 82654251 82654750 −1.05 0.19 1.30E-07 −0.97 0.29 4.68E-04 0.95 0.31 1.53E-03 0.88 0.27 5.94E-04
Chr19 6165251 6165750 0.94 0.18 1.40E-07 0.89 0.25 1.90E-04 −0.88 0.28 9.35E-04 −1.02 0.23 7.36E-06
Chr1 85522251 85522750 0.99 0.18 1.43E-07 1.54 0.25 4.48E-09 −1.53 0.25 7.41E-09 −0.80 0.28 2.32E-03
Chr17 42569001 42569500 −1.07 0.19 1.64E-07 −1.25 0.27 2.21E-06 1.30 0.28 3.81E-06 1.21 0.26 2.44E-06
Chr4 141606501 141607000 1.09 0.19 2.03E-07 1.26 0.26 3.56E-06 −1.33 0.30 1.05E-05 −1.13 0.26 1.83E-05
Chr5 137736001 137736500 −1.03 0.19 2.06E-07 −1.11 0.28 4.12E-05 1.13 0.30 1.39E-04 1.10 0.27 3.78E-05
Chr5 150614501 150615000 −1.08 0.21 2.14E-07 −1.2 0.29 2.80E-05 1.24 0.31 3.18E-05 1.07 0.29 1.21E-04
Chr17 36918251 36918750 −1.1 0.21 2.32E-07 −0.96 0.29 6.01E-04 1.05 0.31 4.88E-04 1.03 0.28 1.83E-04
Chr6 126138251 126138750 −0.99 0.19 2.36E-07 −0.75 0.27 3.29E-03 0.79 0.30 4.92E-03 1.22 0.25 8.94E-07
Chr7 144431251 144431750 1.02 0.19 2.70E-07 0.84 0.28 1.30E-03 −0.85 0.28 1.48E-03 −1.17 0.27 1.77E-05
Chr12 70937251 70937750 0.88 0.17 2.76E-07 0.72 0.23 1.12E-03 −0.87 0.26 5.26E-04 −0.94 0.20 3.10E-06
Chr4 141606251 141606750 1.01 0.19 2.80E-07 1.16 0.26 8.05E-06 −1.31 0.29 6.93E-06 −1.04 0.25 2.14E-05
Chr13 90019001 90019500 1.06 0.2 2.84E-07 1.25 0.29 8.88E-06 −1.36 0.30 5.09E-06 −0.84 0.29 2.20E-03
Chr11 74179001 74179500 1.07 0.2 2.92E-07 1.3 0.29 7.25E-06 −1.37 0.29 3.15E-06 −1.06 0.29 1.76E-04
Chr12 99153001 99153500 −1.01 0.2 3.93E-07 −1.02 0.29 2.02E-04 1.02 0.31 4.59E-04 1.24 0.27 3.77E-06
Chr2 223336751 223337250 −1.01 0.2 4.47E-07 −1.41 0.28 4.00E-07 1.50 0.29 1.69E-07 0.77 0.29 4.65E-03
Chr8 120972001 120972500 0.97 0.19 4.98E-07 0.83 0.27 1.22E-03 −0.87 0.29 1.43E-03 −0.96 0.26 1.81E-04
Chr17 38047001 38047500 −1.04 0.2 5.25E-07 −1.3 0.28 4.51E-06 1.31 0.27 1.21E-06 0.74 0.28 5.39E-03
Chr4 64626751 64627250 −0.99 0.19 5.45E-07 −0.87 0.28 9.92E-04 0.86 0.29 1.61E-03 0.98 0.26 1.36E-04
Chr16 87256751 87257250 −0.83 0.16 5.51E-07 −0.97 0.23 1.75E-05 0.94 0.25 9.13E-05 0.82 0.24 3.37E-04
Chr19 10656751 10657250 −1.03 0.2 5.77E-07 −1.09 0.28 6.47E-05 1.17 0.29 3.80E-05 1.13 0.27 2.18E-05
Chr7 2487251 2487750 0.8 0.16 5.85E-07 0.73 0.23 1.06E-03 −0.81 0.24 5.61E-04 −0.94 0.23 3.49E-05
Chr11 74178751 74179250 0.99 0.2 6.82E-07 1.19 0.28 2.15E-05 −1.15 0.28 2.45E-05 −0.82 0.28 2.37E-03
Chr10 119176501 119177000 −1.04 0.2 6.87E-07 −1.03 0.29 3.41E-04 1.16 0.31 1.69E-04 1.14 0.28 4.83E-05
Chr22 34755251 34755750 −0.98 0.2 7.32E-07 −0.8 0.28 2.35E-03 0.97 0.31 1.21E-03 1.15 0.25 3.95E-06
Chr6 161664751 161665250 0.98 0.19 7.42E-07 0.9 0.26 3.89E-04 −0.83 0.29 2.48E-03 −0.81 0.25 7.71E-04
Chr16 17161751 17162250 −1.01 0.2 7.80E-07 −0.99 0.28 2.19E-04 1.17 0.30 4.48E-05 1.08 0.28 1.16E-04
Chr18 23695001 23695500 1.04 0.21 8.39E-07 0.95 0.29 5.83E-04 −1.04 0.32 6.05E-04 −1.11 0.28 3.96E-05
Chr9 26364751 26365250 −0.95 0.19 8.90E-07 −0.96 0.28 2.78E-04 1.13 0.30 9.90E-05 0.96 0.28 2.77E-04
Chr1 25227001 25227500 −0.83 0.17 9.05E-07 −0.87 0.25 3.81E-04 0.78 0.25 1.39E-03 0.99 0.25 5.78E-05
Chr13 68877251 68877750 0.97 0.2 9.43E-07 1.01 0.28 1.44E-04 −1.24 0.28 1.05E-05 −0.84 0.28 1.39E-03
Chr9 89126501 89127000 −0.92 0.19 9.59E-07 −1.14 0.26 9.49E-06 1.10 0.28 6.62E-05 0.76 0.26 2.12E-03
Chr13 35317501 35318000 −0.96 0.2 9.72E-07 −0.54 0.29 4.44E-02 0.54 0.31 6.52E-02 1.04 0.27 7.61E-05
Chr21 19575001 19575500 0.96 0.19 9.92E-07 0.88 0.27 8.63E-04 −0.96 0.30 8.25E-04 −1.13 0.26 1.24E-05
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Table 3 Effect of ICSI on the FDR 25% WBC IVF-DMRs (Continued)
Chr2 169470001 169470500 −1.02 0.21 1.06E-06 −1.31 0.28 2.08E-06 1.33 0.29 6.99E-06 1.04 0.27 5.91E-05
Chr12 4310251 4310750 −0.99 0.2 1.06E-06 −0.91 0.29 8.79E-04 1.02 0.30 4.54E-04 0.87 0.30 1.99E-03
Chr6 157136501 157137000 −0.96 0.19 1.15E-06 −0.78 0.27 2.19E-03 0.91 0.30 1.37E-03 1.30 0.25 1.62E-07
Chr14 104067251 104067750 0.71 0.14 1.17E-06 0.81 0.21 7.35E-05 −0.75 0.22 3.89E-04 −0.58 0.24 9.44E-03
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the second most associated DMR in that locus
(Additional file 1: Figure S3). Within the sample of 36
MZ twins we also observed higher methylation in the
IVF group, consistent with the MeDIP-seq signal, with
effects close to nominal significance (P = 0.08; Additional
file 1: Figure S4). However, correlation between the
MeDIP-seq signal at the most-associated DMR in TNP1
and the EpiTYPER methylation values was, as expected,
relatively low as we were unable to target CpG sites
within this most-associated DMR (correlation of 0.18
and 0 at the two tested CpG sites). We profiled add-
itional samples from DZ twin pairs but did not obtain
validation of the signal.
We also considered the effect of ICSI compared to
conventional IVF in MZ twins in the validation dataset.
We observed significantly higher methylation in the ICSI
group at the first CpG of the targeted region near TNP1
and at the first CpG site of C9orf3 (Additional file 1:
Figure S5).
Lastly, we also compared methylation in relation to
conception method at the H19 CTCF6 DMR in a re-
duced subset of CBMCs samples (n = 42 twins) using
EpiTYPER. When comparing IVF to non-IVF twins
(Additional file 1: Figure S6) we observed a difference
with the same direction of effect as in the MeDIP-seq
analysis, although not significant (P = 0.19). Interestingly,
when comparing naturally conceived twins to twins that
were conceived with any type of medical help
(Additional file 1: Figure S6), i.e. not exclusively IVF, the
difference reached nominal significance (P = 0.04),
suggesting that differential methylation at this region is
associated with parental subfertility rather than IVF
conception.
Discussion
Since IVF procedures are carried out during an important
period of epigenetic reprogramming in early development,
we hypothesised that IVF may induce epigenetic differ-
ences that persist to birth. We were able to identify signifi-
cant and suggestive DMRs related to IVF conception
(IVF-DMRs) in WBCs, although our results suggest that
at least some of these changes may be linked to parental
subfertility, which is confounded with IVF treatment. The
observation that IVF-DMRs were identified close to genes
implicated in fertility and reproduction suggests that agenetic signature influencing DNA methylation could be
transmitted from parent to offspring. To assess this fur-
ther, we estimated the heritability of the IVF-DMRs. We
observed that the IVF-DMR located in C9orf3, a gene as-
sociated with polycystic ovary syndrome, was estimated to
have a heritability at 25% and eight other FDR 25% WBC
IVF-DMRs showed heritability greater than this (Fig. 3).
Epigenetic states of metastable epialleles in mammals
are mitotically inherited after establishment in early
development, therefore shared across tissues, and can
cause expression variability within isogenic individuals
[45]. A study in humans looking for systematic inter-
individual variation in DNA methylation across tissues
from two different lineages identified 109 candidate
metastable epialleles [40]. Nutritional conditions during
conception have been shown to be important to the
establishment of epigenetic states at some of these meta-
stable epialleles [46]. If an influence of IVF on the epi-
genetic marks of these alleles exists, it could potentially
cause long lasting effects. A previous study, which in-
cluded newborns from single and multiple pregnancies,
identified DNA methylation differences in IVF concep-
tion at candidate metastable epialleles, although at dif-
ferent epialleles to those affected by maternal nutritional
factors [19]. In our study, none of the 109 candidate
metastable epialleles overlapped with the 46 FDR 25%
WBC IVF-DMRs. This discrepancy could be attributed
to differences between single and multiple pregnancies
or to low power to detect such changes.
Our results also showed that IVF-DMRs, including hy-
pomethylation of the regulatory region of H19, were
generally not shared between WBCs and CBMCs. This
observation suggests that the epigenetic differences
reported here likely did not appear during early develop-
ment or that these effects are not fixed and can revert in
a cell type-specific manner. CBMCs, in contrast to
WBCs, lack the granulocyte fraction, which is the
predominant group of cells in the blood. Thus, the IVF-
DMRs may be granulocyte-specific or at least in part
influenced by this group of cells.
To date, there has been mixed evidence on the effect of
IVF at imprinted genes and their regulatory regions. Some
studies have reported DNA methylation changes or in-
creased variability at these imprinted regions [14–16],
while others have reported no associated changes [47, 48].
We observed that there is not an overall destabilisation of
Castillo-Fernandez et al. Genome Medicine  (2017) 9:28 Page 12 of 15methylation patterns in ICRs, but specific DMRs, such as
the H19 DMR, can show a weak but nominally significant
association with the method of conception. Previous stud-
ies have reported similar observations, that is, changes in
methylation at some imprinted regions, but not in the ma-
jority [19, 48]. It is unknown if these changes occur due to
IVF since imprinting defects have been previously
described in sperm of infertile men, including hypomethy-
lation of the H19 CTCF6 DMR [49]. Loke et al. [16] re-
ported that hypomethylation at this locus in buccal
epithelium of newborns in the IVF group was driven by
the subgroup conceived by ICSI. However, it is difficult to
dissect whether the observed effect on DNA methylation
of ICSI-conceived newborns is due to the technique itself
or to male infertility. Whitelaw et al. [50] found higher
levels of SNRPN methylation in buccal cells of ICSI-
conceived newborns and these were associated with longer
duration of infertility in the parents. In our data, we
observed that the difference at the H19 CTCF6 DMR was
greater when considering any type of medical help during
conception, supporting the idea that parental subfertility
is the driver of methylation changes at this region.
Information about the indication for assisted reproductive
technology, the use of donor eggs or sperm, and the fertility
status of parents in the control group would be required to
further assess the effect of parental subfertility.
Adverse perinatal outcomes and increased frequency
of imprinting disorders have also been observed in off-
spring of couples with a history of subfertility that were
able to conceive naturally [51–53]. However, studies
that controlled for parental subfertility by comparing
siblings in which one was conceived naturally and the
other by IVF also observed an effect [54]. It is likely,
therefore, that both parental subfertility and IVF may
induce epigenetic changes, as observed in another
genome-wide study that found DNA methylation differ-
ences between IVF-conceived newborns and a group
conceived through intrauterine insemination (infertile
controls), but also between the latter and naturally con-
ceived newborns (fertile controls) [19]. In addition, a
study looking at 37 candidate CpG sites identified seven
that were differentially methylated when comparing an
IVF-conceived group born to parents without male in-
fertility that used donor oocytes to naturally conceived
newborns [55].
Finally, two IVF-DMRs associated with infertility
(TNP1 and C9orf3) were targeted for validation. Differ-
ential methylation was validated at the C9orf3 gene.
However, validation of the TNP1 region was hampered
by our inability to target CpG sites within the most-
associated DMR in this locus. We attempted validation
at TNP1 by targeting CpG sites in the neighbouring 500-
bp bin and observed consistent direction of association
close to nominal significance.In this study the non-IVF group included a set of twins
conceived after GIFT and another set conceived after
ovarian stimulation not followed by IVF. GIFT and ovar-
ian stimulation are fertility treatments not equivalent to
IVF since fertilisation still occurs in the fallopian tubes.
We showed that our results were not affected by the in-
clusion of these data, potentially because they were repre-
sented in small numbers, only four out of 58 samples.
Limitations
There are several limitations in this study. First, it is known
that cell composition may represent a confounding variable
in EWAS [56]. Our results use principal component ana-
lysis anticipating that these will capture cell heterogeneity,
and follow-up of our findings in a subset of twins with
available cell counts showed that the majority of findings
remained significant after adjustment for cell heterogeneity.
Second, although MeDIP-seq has the strength of genome-
wide coverage, it lacks base-pair resolution, instead generat-
ing methylation scores across genomic regions. However, it
has been reported that methylation of neighbouring CpG
sites is correlated over distances up to 1000 bp [57], sug-
gesting that the approach may be able to capture a good
proportion of the methylation variance in a genomic region.
Third, although this study includes a sample size larger
than most previous studies exploring IVF, contemporary
EWAS study designs generally require larger numbers of
cases and controls to achieve sufficient power to detect
small to moderate effect sizes [21, 58]. Lastly, our approach
cannot conclusively determine the cause of the observed
IVF-associated methylation changes. Future studies of IVF-
associated regions in animal models, where genetic differ-
ences and infertility diseases can be discarded, could help
identify if these changes were caused by IVF itself.
Conclusions
We observed evidence for differences in DNA methylation
between IVF and non-IVF twins on a genome-wide scale. A
strength of this study design is that it allowed us to also es-
timate the contribution of genetic and environmental fac-
tors towards DNA methylation levels at the IVF-associated
loci. The inclusion of only twin pregnancies also avoided
biases present in studies that consider single and multiple
pregnancies together. Multiple pregnancies are more
common after IVF. Therefore, the differences observed
when studying singleton and twin births together may be
confounded with the higher risks of adverse perinatal out-
comes in multiple pregnancy births, rather than IVF itself.
Nevertheless, we were unable to dissect whether methyla-
tion changes were likely caused by IVF, or were due to the
underlying parental subfertility, or other factors. These
scenarios require further study exploring the stability of
these DMRs over time, their relation with gene expression,
and their potential role in health and disease.
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